IDT Biologika offers process development and GMP compliant manufacturing of Viral Vaccines, Oncolytic Viruses, Gene and Immunotherapeutics as well as Biologics in its facilities in Germany and US.
In Dessau, Germany we operate one of Europe‘s premiere integrated biological and pharmaceutical development and manufacturing facilities for end-to-end services from development through clinical phase I – III to commercial manufacturing. In Rockville, MA, US we use broad capabilities and a depth of technologies for development and manufacturing of clinical trial material for phase I – II.
With decades of experience in the commercial production of live viral BSL2 vaccines and fill/finish of biologics at our FDA and EMA approved sites (ANVISA ready), IDT Biologika handles every step in process development, manufacturing, quality control and packaging processes. We strive for a strong collaboration with our client partners to support the development of their vaccines and other biopharmaceuticals.